Cargando…

Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release

[Image: see text] Histone deacetylase inhibitors (HDACi) target abnormal epigenetic states associated with a variety of pathologies, including cancer. Here, the development of a prodrug of the canonical broad-spectrum HDACi suberoylanilide hydroxamic acid (SAHA) is described. Although hydroxamic aci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniel, Kevin B., Sullivan, Eric D., Chen, Yao, Chan, Joshua C., Jennings, Patricia A., Fierke, Carol A., Cohen, Seth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2015
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467547/ https://www.ncbi.nlm.nih.gov/pubmed/25974739 http://dx.doi.org/10.1021/acs.jmedchem.5b00539

Ejemplares similares

Prodrug Based on Ionic Liquids for Dual-Triggered Release of Thiabendazole
por: Zhang, Wenbing, et al.
Publicado: (2023)

Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition
por: King, Kristina, et al.
Publicado: (2018)

Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates
por: Varga, Julia K., et al.
Publicado: (2022)

Modification of proteins with covalent lipids
por: Olson, Eric N.
Publicado: (1988)

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2014)

Targeting Cytotoxic Agents through EGFR-Mediated Covalent Binding and Release
por: Morese, Pasquale A., et al.
Publicado: (2023)

The covalent modification of eukaryotic proteins with lipid
Publicado: (1987)

A Multipronged Approach Establishes Covalent Modification of β-Tubulin as the Mode of Action of Benzamide Anti-cancer Toxins
por: Povedano, Juan Manuel, et al.
Publicado: (2020)

Antibody-Based Imaging of Bioreductive Prodrug Release in Hypoxia
por: Tosun, Çağla, et al.
Publicado: (2023)

Click Chemistry Enabling Covalent and Non-Covalent Modifications of Graphene with (Poly)saccharides
por: Li, Hu, et al.
Publicado: (2020)

Benzene Tetraamide: A Covalent Supramolecular Dual Motif in Dynamic Covalent Polymer Networks
por: Zhang, Huiyi, et al.
Publicado: (2023)

Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs
por: Deng, Chaoyi, et al.
Publicado: (2022)

Collaborative Action of Brca1 and CtIP in Elimination of Covalent Modifications from Double-Strand Breaks to Facilitate Subsequent Break Repair
por: Nakamura, Kyoko, et al.
Publicado: (2010)

A Year-Long Extended Release Nanoformulated Cabotegravir Prodrug
por: Kulkarni, Tanmay A., et al.
Publicado: (2020)

Linking the epigenetic ‘language’ of covalent histone modifications to cancer
por: Hake, S B, et al.
Publicado: (2004)

The Post-Translational Modifications, Localization, and Mode of Attachment of Non-Covalently Bound Glucanosyltransglycosylases of Yeast Cell Wall as a Key to Understanding their Functioning
por: Rekstina, Valentina V., et al.
Publicado: (2020)

Dual Stimuli-Responsive Dynamic Covalent Peptide Tags: Toward Sequence-Controlled Release in Tumor-like Microenvironments
por: Zegota, Maksymilian Marek, et al.
Publicado: (2021)

Uncoupling Transcription from Covalent Histone Modification
por: Zhang, Hesheng, et al.
Publicado: (2014)

Chemical strategies for the covalent modification of filamentous phage
por: Bernard, Jenna M. L., et al.
Publicado: (2014)

d‐ Versus l‐Glucose Conjugation: Mitochondrial Targeting of a Light‐Activated Dual‐Mode‐of‐Action Ruthenium‐Based Anticancer Prodrug
por: Lameijer, Lucien N., et al.
Publicado: (2016)

Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA
por: Peng, Zheng-Hong, et al.
Publicado: (2017)

Synthesis, characterization and in vitro release performance of the pegylated valnemulin prodrug
por: DONG, Xinrui, et al.
Publicado: (2017)

Association Between Mode of First Delivery and Subsequent Fecundity and Fertility
por: Kjerulff, Kristen H., et al.
Publicado: (2020)

Expanding lignin thermal property space by fractionation and covalent modification
por: Riddell, Luke A., et al.
Publicado: (2023)

Emerging roles of histone modifications and HDACs in RNA splicing
por: Rahhal, Raneen, et al.
Publicado: (2019)

Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
por: Zhang, Changde, et al.
Publicado: (2019)

Rhenium(V) Complexes as Cysteine-Targeting Coordinate Covalent Warheads
por: Karges, Johannes, et al.
Publicado: (2023)

Covalent immobilization of gold nanoparticles on a plastic substrate and subsequent immobilization of biomolecules
por: Matsumoto, Mimari, et al.
Publicado: (2021)

Physiological relevance of covalent protein modification by dietary isothiocyanates
por: Nakamura, Toshiyuki, et al.
Publicado: (2018)

Ultrasensitivity and bistability in covalent-modification cycles with positive autoregulation
por: Jeynes-Smith, Cailan, et al.
Publicado: (2021)

Editorial: Computational Resources for Understanding Biomacromolecular Covalent Modifications
por: Xue, Yu, et al.
Publicado: (2021)

Covalent Chemical Tools for Profiling Post-Translational Modifications
por: Emenike, Benjamin, et al.
Publicado: (2022)

Carnitine Conjugate of Nipecotic Acid: A New Example of Dual Prodrug
por: Napolitano, Carmela, et al.
Publicado: (2009)

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
por: Kastner, Alexander, et al.
Publicado: (2023)

Dual Mechanisms of HNO Generation by a Nitroxyl Prodrug of the Diazeniumdiolate (NONOate) Class
por: Andrei, Daniela, et al.
Publicado: (2010)

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
por: Sinatra, Laura, et al.
Publicado: (2020)

The evolution of RNase P
por: Engelke, David R., et al.
Publicado: (2015)

Covalent modification of a ten-residue cationic antimicrobial peptide with levofloxacin
por: Rodriguez, Carlos A., et al.
Publicado: (2014)

Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin
por: Üllen, Andreas, et al.
Publicado: (2015)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u1t27aggb1kl04hcg8r1cv219r